In Santa Clara, the delegation from Songshan Lake of Dongguan visited NVIDIA, the world leader in visual computing technologies and one of Silicon Valley’s cutting-edge companies.
Precept 2: Broaden investment channels; create a new model for business invitation and promotion.
Ji Tongkai (Dean of Guangdong Electronics Industry Research Institute and President of Guoyun Science and Technology Co. Ltd) was appointed to the Chinese delegation as an additional industrial consultant for the second stateside visit in June. This visit to the U.S. and Canada was not primarily geared towards investment invitation, but rather towards promoting mutually beneficial business cooperation opportunities. To this end, the delegation visited several locations during their tour.
The cloud computing platform of Guangdong Electronics Industry Research Institute and Guoyun Technology was brought directly from Songshan Lake to the meeting with AMAX. AMAX, who specialize in high-performance computer cluster development, discussed their “CloudMax Private Cloud Solution” project very openly and decided that Chaobo Electronics would carry out the cooperation with Guoyun Technology.
In Santa Clara, the Chinese delegation visited AMAX’s close business partner NVIDIA, who are the world leader in visual computing technologies and one of Silicon Valley’s cutting-edge companies. The delegation presented NVIDIA with details of Songshan Lake’s investment environment, and the cloud computing platform. Their Vice-President Mr. Shanker Trivedi gave high praise to the beautiful environment of the Songshan Lake collective, and showed interest in the cloud computing technology. Ultimately, he was supportive of some venture in China, and recently NVIDIA’s Shenzhen based leader began to initiate cooperation with Guoyun Technology regarding the cloud computing technology.
In Fremont, the delegation visited VM Discovery and Amkey Ventures. VM Discovery owns nearly ten innovative patents for American and international (PCT) drug molecules. Two of these have been cleared for, and begun, human clinical trials in the United States. Amkey, an official shareholder of VM, is a Californian venture capital company, whose focus is in the biotechnology industry. Li Hang introduced the development of Songshan Lake’s biomedical industry, and also outlined other relevant existing platforms. He suggested that VM may find a partnership with East Sun Company attractive, as together they could cooperate on developing new pharmaceuticals. Alternatively, delegates could assist with arranging some kind of alternative cooperation towards a similar end.
Li Hang also proposed methods where they could seek a venture capital company based in Songshan Lake for some joint venture initiative concerning innovative drug molecules projects. VM President Dr. Wu said that he had already contacted many domestic high-tech companies in Songshan Lake, and found that their innovative ideas and pragmatic leadership styles had left a deep impression on him.